As pediatricians, we say please don’t use precious coronavirus vaccines on healthy children

In March, three months after its coronavirus vaccine was authorized in the United States and Europe, Pfizer and BioNTech reported the successful results of a trial in adolescents. The companies also initiated studies in children as young as 6 months old. Vaccine maker Moderna has also performed studies in adolescents and younger children. On Monday, the Food and Drug Administration granted authorization of Pfizer-BioNTech’s vaccine for 12- to 15-year-olds. An application for children ages 2 to 11 may be forthcoming in September.